ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

January 27, 2006

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

NCI Plans a Catalog Of Research Tools

April 30, 1999

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996